OPUS GENETICS INC. - COMMON STOCK
1.1800
01-November-24 14:59:56
15 minutes delayed
Stocks
-0.0200
-1.67%
Today's range
1.1600 - 1.2185
ISIN
N/A
Source
NASDAQ
-
Ocuphire Pharma Announces Acquisition of Opus Genetics
22 Oct 2024 15:05:00 By Nasdaq GlobeNewswire
-
30 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
05 Sep 2024 19:43:59 By Nasdaq GlobeNewswire
-
05 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Second Quarter 2024 and Provides Corporate Update
13 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at Two Investor Conferences in August
08 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma to Highlight APX3330 for Diabetic Retinopathy at Two Scientific Meetings in July
10 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
06 Jun 2024 06:57:22 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update
10 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting
06 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at the Aegis Virtual Conference
03 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting
22 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
01 Apr 2024 06:14:52 By Nasdaq GlobeNewswire
-
08 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present in the BIO CEO & Investor Conference
23 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 Feb 2024 15:10:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Strengthens Leadership Team with Key Appointments
14 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
05 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24 Jan 2024 15:10:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >